Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Heart weakness is a serious possible development from an L-carnitine deficiency left unchecked
Key Development: February 2026: The Phase 3 TRIUMPH-1 trial results for orforglipron showed a mean body weight reduction of 14.7% at 36 weeks in adults with obesity without diabetes, according to Eli Lilly and Company
One woman in Louisiana has filed a lawsuit against the makers of Ozempic after allegedly suffering from severe gastrointestinal issues
At the mechanistic level, the hypothesized link between NSW and BC is grounded in the concept of circadian disruption 12
These drugs have received approval by FDA and achieved successful entry to market, bolstering our confidence in the clinical potential of our oridonin
Practical nausea management Eat smaller, more frequent meals instead of three large ones
.png)
US$ 28.75
US$ 22.34
US$ 23.22
US$ 28.18
US$ 20.55
US$ 21.12
